COVID-19 vaccination in the United Kingdom

"Margaret Keenan" redirects here. For the American educator, see Margaret Keenan Harrais.

COVID-19 vaccination programme in the United Kingdom

Vial and syringe used for the vaccination of Margaret Keenan, the first COVID-19 vaccine given outside of trials
Date	8 December 2020 (2020-12-08) – present
Location	United Kingdom
Cause	COVID-19 pandemic
Target	Immunisation of the public in the United Kingdom against COVID-19
Participants	53,710,109 have received one vaccine dose 50,483,527 have received two vaccine doses 40,196,024 have received three vaccine doses, 6,200,537 have received a fourth dose [1]
Outcome	92.9% of UK population 12+ have received one vaccine dose 86.8% of UK population 12+ have received two vaccine doses 69% of UK population 12+ have received three vaccine doses [1]
Website	GOV.UK

The percentage of the adult population, by nation, reported to have received 1st dose of a vaccine as of 30 May 2021

GP-led vaccination centres were in operation by 15 December 2020

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.

Vaccinations began on 8 December 2020 after Margaret Keenan became the first person in the world (outside trials) to receive her first dose of two of the Pfizer–BioNTech COVID-19 vaccine. ^[2] There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed by University of Oxford and AstraZeneca (Vaxzevria), and the United States National Institute of Allergy and Infectious Diseases and Moderna (Spikevax) have been rolled out. As of 13 September 2021 ^[update] , there were four other COVID-19 vaccines on order for the programme, at varying stages of development.

Phase 1 of the rollout prioritised the most vulnerable, in a schedule primarily based on age. The delivery plan was adjusted on 30 December 2020, delaying second doses so that more people could receive their first dose. A target to give all 15 million people in the top four priority groups their first dose by the middle of February 2021 was announced on 4 January 2021, and achieved on 14 February 2021. The next five groups were offered a vaccine by 15 April, and 32 million doses were administered by that point. In June 2021, all adults aged 18+ were able to get their first dose of a vaccine. The vaccine rollout was expanded to adolescent children and booster doses during the later months of that year. ^[3] In response to the SARS-CoV-2 Omicron variant, third vaccine doses were made available to all adults in December 2021. ^[4]

The UK's rollout was among the fastest in the world with among the highest uptake in its first few months, ^[2] although vaccination rates had slowed down or plateaued by autumn 2021 due to lower uptake in younger age groups. ^{[5] [6]} Polling suggests the UK's level of COVID-19 vaccine hesitancy is among the world's lowest. ^{[7] [8]}

Vaccination sites include GP practices, care homes and pharmacies, as well as hospitals. As of 21 May 2021 ^[update] , there were 2,057 vaccination sites operating in England. ^[9] There are over 1,100 vaccination sites operating in Scotland. ^[10] As of 25 May 2021, there were 462 vaccination sites operating in Wales. ^[11] Additional sites, including large venues such as sports stadia, entered the programme from 11 January 2021, with seven mass vaccination centres opening in England initially and seven in Wales. ^[12]

New guidance for allergy sufferers, antibody tests, new variants of SARS-CoV-2 (B.1.1.7 and B.1.617) and the use of the AstraZeneca vaccine in younger adults have been issued throughout the programme.

The programme also includes procurement of vaccines for British Overseas Territories and Crown Dependencies. ^{[13] [14]}

According to a June 2022 study published in The Lancet , COVID-19 vaccination in the United Kingdom prevented an additional 507,000 deaths from December 8, 2020 to December 8, 2021. ^{[15] [16]}

Progress, as of 6 October 2021 ^[update]

Home nation	Doses administered per 100 people
United Kingdom	140.95
England	140.20
Scotland	148.08
Wales	146.38
Northern Ireland	133.61
From official vaccination [17] and 2019 ONS [18] [19] [20] [21] data. (Doses may not equate to no. people if more than one dose received.)

Background

Responsibility for deployment

On 28 November 2020 the new role of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was set up within the Department of Health and Social Care in the Government of the United Kingdom, with Nadhim Zahawi the first to take office. ^[22]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world. By February 2021 the British Government had placed orders for a combined total of 457 million doses across 8 different vaccines, ^{[23] [24] [25] [26]} and as of 23 August 2021 this had increased to more than 540 million doses. ^[27] This does not equate to the number of people that can be immunised as most vaccines require more than one dose.

In September 2021, the UK government cancelled their 190-million-dose Valneva order, citing supply concerns. ^[28]

The breakdown of the vaccines currently being considered for the vaccination programme is as follows: ^{[29] [30]}

Vaccine	Origin	Progress	Doses ordered	Approval	Deployment
Pfizer–BioNTech	US/Germany	phase III clinical trials	189 million [27]	2 December 2020	8 December 2020
Oxford–AstraZeneca	UK/Sweden/India	phase III clinical trials	100 million	30 December 2020 [31]	4 January 2021 [32]
Moderna	US	phase III clinical trials	77 million [24]	8 January 2021 [24]	7 April 2021 [33]
Janssen (Johnson & Johnson)	US/Belgium/Netherlands	phase III clinical trials	20 million	28 May 2021 [34]	Pending
Novavax	US/India	phase III clinical trials	60 million	3 February 2022 [35]	Pending
GSK/Sanofi Pasteur	UK/France	phase III clinical trials	60 million	Pending	Pending
CureVac	Germany	phase III clinical trials	50 million [26]	Pending	Pending

History

Regulatory approvals

On 2 December 2020, the UK became the first country to give approval for use of the Pfizer–BioNTech vaccine, ^{[36] [37]} later branded as Comirnaty. ^[38] This was in the form of a temporary authorisation given by the Medicines and Healthcare products Regulatory Agency (MHRA) under Regulation 174 of the Human Medicines Regulations 2012. ^[39] Regulatory approval is reserved under the devolution settlement. The first batch arrived in the UK the next day and was initially stored at an undisclosed central hub before being distributed to hospital vaccination centres across the country. ^[40]

On 30 December 2020, the UK also became the first country to approve the Oxford/AstraZeneca vaccine. ^[31]

On 8 January 2021, the Moderna vaccine was approved as the third vaccine to enter the programme. ^[24]

On 28 January 2021, the results of the Novavax vaccine trials, which were undertaken in the UK and in South Africa, showed it was 95.6% effective against the original SARS-CoV-2 strains and 85.6% against the Variant of Concern 202012/01, then prevalent in the UK. The company stated it had begun the process of requesting clearance for use in the UK. ^[41] The Novavax vaccine was the first to be tested in clinical trials for efficacy against the UK's prevailing Variant of Concern 202012/01. ^[42] In clinical trial subjects without HIV infections, the vaccine was also 60% effective against the 501.V2 variant, a SARS-CoV-2 strain first detected in South Africa. ^[42]

On 28 May 2021, the Janssen vaccine was the fourth vaccine to be approved in the UK. ^[34]

On 3 February 2022, the Novavax vaccine was the fifth vaccine to be approved in the UK. ^[35]

On 14 April 2022, the UK became the first country to approve the Valneva vaccine. This is the sixth COVID-19 vaccine that the MHRA has approved. ^[43]

Rollout timeline

This timeline lists the general availability of vaccine appointments in England, by date. The dates differed slightly in Scotland, Wales and Northern Ireland (not listed here).

Availability of vaccine appointments in England, by date

Start date	Appointments available for	Priority group	Ref
8 December 2020	Residents in a care home for older adults and their carers; and all aged 80 and over	1 and part of 2	[44] [45]
Procedures set out on 9 and 14 January 2021	Frontline health and social care workers	Part of 2	[46] [47]
18 January 2021	All aged 70 and over, and clinically extremely vulnerable individuals	3 and 4	[48]
15 February 2021	All aged 65 and over; and those aged 16 to 64 with underlying health conditions which put them at higher risk of serious disease and mortality	5 and 6	[49]
1 March 2021	All aged 60 and over	7	[50]
6 March 2021	All aged 56 and over	8 (age adjusted from 55)	[51]
17 March 2021	All aged 50 and over	9	[52]
13 April 2021	All aged 45 and over		[53]
26 April 2021	All aged 44 and over		[54]
27 April 2021	All aged 42 and over		[55]
30 April 2021	All aged 40 and over		[56]
13 May 2021	All aged 38 and over		[57]
18 May 2021	All aged 36 and over		[58]
20 May 2021	All aged 34 and over		[59]
22 May 2021	All aged 32 and over		[60]
26 May 2021	All aged 30 and over		[61]
8 June 2021	All aged 25 and over		[62]
15 June 2021	All aged 23 and over		[63]
16 June 2021	All aged 21 and over		[64]
18 June 2021	All adults (ie aged 18 and over)		[65]

A vaccination centre in Finchley, north London, March 2021

On 8 December 2020, Margaret Keenan, 90, became the first person in the world (outside trials) to receive the Pfizer–BioNTech vaccine as the rollout of vaccinations began. ^[44] William Shakespeare, 81, from Warwickshire became the second person, and the first man, to be vaccinated. ^[66] Both vaccinations took place at University Hospital Coventry. On 4 January 2021, Brian Pinker, 82, became the first person (outside trials) to receive the Oxford–AstraZeneca vaccine. The vaccination took place at the Churchill Hospital, Oxford. ^[32] England Health Secretary, Matt Hancock said this was a "pivotal moment" in the programme as this vaccine was easier to transport and store, requiring only ordinary fridge temperatures. Six hospitals in England began the Oxford vaccine rollout using the first batch of around 530,000 doses. ^[67]

The Queen and Prince Philip, then 94 and 99 respectively, received their vaccinations within their Windsor Castle residence on 9 January 2021. ^[68] Prince William cited their example, a week later, to encourage everyone to take up the vaccine ^[69] after hearing that a degree of vaccine hesitancy had set in.

The rollout to the over 70s and clinically extremely vulnerable began on 18 January 2021, ^[48] representing the fourth priority group and the final group needed to complete the government's initial 15 February target. ^[70]

Over 20 million first doses were administered by 28 February 2021. ^[71]

Prime Minister Boris Johnson is given the vaccine by nurse Lily Harrington at St Thomas' Hospital

On 19 March, Prime Minister Boris Johnson received his first dose of the AstraZeneca vaccine at St. Thomas' Hospital. By this point, more than 26 million people had received their first dose of a COVID-19 Vaccine. ^[72]

On 7 April 2021, Elle Taylor, 24, became the first person in the UK (outside trials) to receive the Moderna vaccine. The vaccine was administered on Miss Taylor, an unpaid carer from Ammanford, at Glangwili General Hospital, Carmarthen. ^[73]

Guidance

Queuing for the Oxford-AstraZeneca vaccine in Finchley, North London, March 2021

On 9 December 2020, the MHRA issued updated guidance, after two cases of anaphylaxis and another case of a possible allergic reaction following the vaccination. In the statement, June Raine, MHRA chief executive, said: ^[74]

Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine. A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.

Raine went on to say that such side effects have been known to happen with any vaccine but are "very rare". She continued to confirm that existing appointments should not be cancelled but people with a history of serious allergies should discuss this beforehand. Furthermore, she expressed confidence in the safety, assessment and monitoring of the vaccine. Guidance was given that vaccine recipients should be monitored for at least 15 minutes after vaccination and centres must be prepared for such events including the availability of an anaphylaxis pack. ^[74] The two people affected were quickly treated and recovered well. ^[74]

The Department of Health and Social Care confirmed that although the vaccine triggers the creation of antibodies, vaccination does not affect the result of an antibody test to detect whether someone has previously contracted the virus. This is because there are differences between the antibodies triggered and those being tested for. ^[75]

As of 20 December 2020 ^[update] , Public Health England said there is "no evidence" to suggest that the recently identified Variant of Concern 202012/01 (a new variant of SARS-CoV-2) would be resistant to the Pfizer–BioNTech vaccine currently being used in the programme, and people should still be protected. ^[76]

As of 8 April 2021 ^[update] , the JCVI issued advice to the government stating "that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the Oxford-AstraZeneca vaccine where available, following reports of extremely rare blood clots in a very small number of people." ^[77]

As of 7 May 2021 ^[update] , the JCVI issued advice to the government stating "the JCVI has advised a preference for adults aged 30 to 39 without underlying health conditions to receive an alternative to the Oxford/AstraZeneca vaccine – where available and only if this does not cause substantial delays in being vaccinated, on extremely rare cases of concurrent thrombosis (blood clots) and thrombocytopenia (low platelet count) following the first dose of the Oxford/AstraZeneca vaccine." ^[78]

As of 16 June 2021 ^[update] it was expected that vaccination would become mandatory for those working in aged care (excluding those medically exempt). ^[64]

Companies and organisations involved

In the months before approval of the first vaccine, the Joint Committee on Vaccination and Immunisation (an independent group of experts) gave advice to the Vaccine Taskforce on the groups of people that should be prioritised for vaccination. ^{[79] [80]} The taskforce was formed in May 2020 to lead efforts to develop, manufacture and procure vaccines for the UK and globally, ^[81] and was led until the end of 2020 by biotech venture capital manager Kate Bingham. ^[82]

As with other licensed vaccines, the National Institute for Biological Standards and Control (part of the MHRA) reviews the production process and the manufacturer's quality control, and tests each batch of vaccine. ^[83] Again in common with other vaccines and medicines, the MHRA monitors adverse reactions by collecting details submitted by healthcare workers, carers and the public through the Yellow Card Scheme; the agency set up a web reporting site specific to the COVID-19 vaccines. ^[84]

The creation of the Vaccines Manufacturing and Innovation Centre was announced in December 2018, to provide the UK with a vaccine development and manufacturing facility, and its building is under construction at Harwell with planned completion brought forward from 2022 to 2021. The academic/industrial consortium assisted with development and early production of the Oxford–AstraZeneca vaccine during 2020. ^[85] Services contractor Serco has a role in the deployment, as part of a contract which was extended for six months in June 2021 at a cost of £424 million. ^[86]

The British Armed Forces have assisted with the vaccine rollout through the COVID Support Force in all parts of the UK. This has involved assistance with planning, the construction of vaccination centres and the contribution of staff to administer vaccines. This support is provided through the provisions of the military aid to the civil authorities (MACA) mechanism and is part of the military's wider contribution under Operation Rescript. ^[87]

Planning

AstraZeneca vaccine vial and a NHS patient COVID-19 vaccination record card at a NHS vaccination centre

Delivery plan

During the rollout of the Pfizer–BioNTech vaccine first doses, the UK government announced on 30 December 2020 that future deployment would focus on that initial dose, rather than giving the required two doses as quickly as possible. The announcement of this plan coincided with the approval of the Oxford–AstraZeneca vaccine, and so represented the strategy to roll out the two vaccines. The government stated that prioritising the first dose was on advice from the Joint Committee on Vaccination and Immunisation (JCVI) and further assured that everyone would still receive their second dose within 12 weeks of their first. ^[31] Despite this, Margaret Keenan, who was the first person outside of trials to receive a dose of the Pfizer–BioNTech vaccine, returned to hospital on 29 December 2020 for her follow-up injection. This was exactly three weeks after her first, in accordance with the original plan until the announcement of the new strategy. By receiving her second dose, Keenan completed the vaccination process. ^[88]

The new plan to increase the gap between first and second doses from 3 to 12 weeks was criticised as "unfair" by the British Medical Association (BMA) on 31 December 2020, as appointments booked for 4 January 2021 or later would have to be rescheduled. ^[89] In response, all four Chief Medical Officers (CMO), plus England's Deputy CMO Jonathan Van-Tam, signed an open letter explaining the policy shift. ^[90] They said by prioritising first doses, more people would have substantial protection faster, and the second dose adds relatively minor additional protection in the short term. They went on to say that for every 1,000 people given the second 'booster' dose, 1,000 new people would not be able to have up to 70% protection and would instead remain totally unprotected.

Delivery targets

During his address announcing England's third national lockdown on 4 January 2021, Boris Johnson indicated a preliminary target for the vaccination programme, saying: ^[70]

By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination and Immunisation.

He went on to confirm this would include all elderly residents of care homes and indeed everyone over the age of 70, as well as all frontline health and social care workers, and all those who are "clinically extremely vulnerable".

Vaughan Gething, Minister for Health and Social Services in the Welsh Government, matched England's targets by announcing that all people in groups 1–4 would be offered a first dose by mid February. ^[91]

A vaccination plan was published by the Scottish Government on 14 January. ^[92] Part of this plan, subsequently withdrawn after objections from central government, projected the numbers of doses of vaccines delivered weekly to Scotland from the British Government until May, estimating that by mid-March there would be enough doses there to supply every person in the priority groups with their first doses, and enough doses by July to supply every adult with both doses. ^[93] Extrapolating from these figures, Sky News estimated that supply for the UK overall would be sufficient to meet the British Government's aim of immunising all 15 million priority individuals in the country by mid-February, and vaccinating all adults in Britain with their first dose by mid-July. ^[93]

Vaccine priority groups

A care home in Castleford, West Yorkshire with sign reading "Proud to be Covid(sic) Vaccinated"

Phase 1

The JCVI advised the governments on how to prioritise the rollout. The top priority for the programme was to prevent deaths and to ensure that the National Health Service (NHS) would not be overwhelmed, and as older people are more at risk of hospitalisation or death from COVID-19, prioritisation was primarily based on age. ^[94]

The table shows the priority groups for the first phase of the roll-out. ^[94] An estimate of the number of people in each group in the United Kingdom is also shown ^[95] (but note that some people fall into more than one group).

Order	Priority group	Number eligible (estimated) [95]
1	residents in a care home for older adults and their carers	0.8M
2	all those aged 80 years and over, and frontline health and social care workers	7.1M
3	all those aged 75 years and over	2.3M
4	all those aged 70 years and over, and clinically extremely vulnerable individuals	4.4M
5	all those aged 65 years and over	2.9M
6	all those aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality	7.3M
7	all those aged 60 years and over	1.8M
8	all those aged 55 years and over	2.4M
9	all those aged 50 years and over	2.8M

Breakdown of sizes of high-priority groups for COVID-19 vaccination in the UK

"Clinically extremely vulnerable" is defined as: ^[97]

• solid organ transplant recipients
• people with specific cancers:
  • people with cancer who are undergoing active chemotherapy
  • people with lung cancer who are undergoing radical radiotherapy
  • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
  • people having immunotherapy or other continuing antibody treatments for cancer
  • people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
  • people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
• people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
• people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
• people on immunosuppression therapies sufficient to significantly increase risk of infection
• people with spleen problems, e.g. splenectomy (spleen removal)
• adults with Down's syndrome
• adults on dialysis or with chronic kidney disease (stage 5)
• other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs.

Women who are pregnant and children under 16 are not defined as clinically extremely vulnerable for the purpose of the vaccination programme. ^[94]

Polish group Omni Calculator developed a tool which estimates when individuals will receive the vaccine, based on age, employment, and health status. ^{[98] [99]}

"People with underlying health conditions which put them at higher risk of serious disease and mortality" is defined as: ^[100]

• people with long-term lung conditions (such as severe asthma, COPD, bronchiectasis and cystic fibrosis)
• people with long-term conditions affecting the heart or blood vessels (such as congenital heart disease, heart failure and peripheral arterial disease):
• people with diabetes
• people with chronic kidney disease
• people with long-term liver conditions (such as cirrhosis and hepatitis)
• people with conditions affecting the brain or nerves (such as dementia, Parkinson's disease, motor neurone disease, multiple sclerosis, epilepsy, cerebral palsy or stroke)
• people with learning disabilities
• people with a condition or treatment that makes you more likely to get infections (such as HIV or some treatments for lupus, psoriasis or rheumatoid arthritis)
• people with severe mental health conditions (such as schizophrenia and bipolar disorder)
• people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
• people on immunosuppression therapies sufficient to significantly increase risk of infection
• People with severe obesity (a BMI of 40 or above)

^[94]

Phase 2

The JCVI released an interim statement on 26 February 2021 regarding the rollout of the vaccine in Phase 2. It was decided that Phase 2 would not rollout by occupation or ethnicity but instead solely on age. The order therefore in Phase 2 is as follows: ^[101]

Order	Priority group	Number eligible (estimated)
10	all those aged 40 to 49 years	~21 million [102]
11	all those aged 30 to 39 years
12	all those aged 18 to 29 years

The JCVI also noted that males from BAME backgrounds and those with a BMI over 30 were at an increased risk, and therefore stated that it "strongly advises that individuals in these groups promptly take up the offer of vaccination when they are offered", with local officials advised to "promote vaccination in these groups". ^[101] Poorer neighbourhoods should also be subject to an outreach programme by local officials. The UK government said it aimed to offer all adults over the age of 18 a vaccine before 31 July 2021. ^[102]

The decision not to prioritise people in high-risk public-facing occupations such as teachers, police officers and bus drivers was criticised by the Association of School and College Leaders, NASUWT and the Metropolitan Police Federation. Asthma UK also criticised the lack of prioritisation of those with mild or moderate asthma in either Phase 1 or Phase 2. ^[102] JCVI chair Wei Shen Lim defended the rollout plan, stating "speed of deployment is the most important factor" and that rollout by occupation would slow down vaccinations. ^[102]

Juveniles

Healthy individuals under the age of 18, and all under 16s, were not part of the initial vaccine rollout, on the grounds of their relatively low risk from the virus and the then limited availability of evidence relating to COVID-19 vaccines' effects on young people. ^{[94] [101]} On 19 July 2021, the vaccine rollout was expanded to vulnerable adolescents from the age of 12 and young people in the three months prior to their 18th birthday. ^[103] They were joined by all 16- and 17-year-olds on 4 August. ^[104] The Vaccinations Committee did not endorse vaccines for healthy 12- to 15-year-olds, on the grounds of only 'marginal gain' to the health of individual children. ^[105] However, the UK's chief medical officers agreed to the rollout of a single dose of the Pfizer vaccine to this age group on 13 September in order to reduce disruption to education. ^[106] Second doses, three months or more after their first, were expanded to this age range on 29 November. ^[107]

On 15 and 16 February 2022, plans were announced across the UK to expand the Pfizer vaccine rollout to children from the age of five; ^[108] the Vaccinations Committee approved this, taking into account an estimate that over 85% of all children aged 5 to 11 had experienced COVID-19 infection by the end of the previous month. ^[109] That plan was later reversed, with no children under 12 being eligible after 1 September 2022 except for those in high-risk groups. ^[110]

Booster doses

In September 2021, booster doses began to be given to members of the following groups, six months after their second vaccine dose:

• people over the age of 50
• vulnerable people over 16
• health and social care workers
• adult members of the households of immune-suppressed individuals ^[111]

It was decided in November that healthy people in their forties would also be eligible for a booster vaccination. ^[112] Later that month, booster vaccinations were expanded to everyone over the age of 18 who had received their second dose more than three months earlier, whilst some people with severe immunosuppression became eligible for a fourth dose in response to the SARS-CoV-2 Omicron variant. ^[107] In December, the booster programme was further expanded to offer all adults a booster dose by the end of 2021. ^[4]

Further booster doses were offered from February 2022 for people who had received their previous dose around six months earlier and were:

• aged 75 years or older,
• resident in a care home for older adults,
• aged 12 years or over and immunosuppressed. ^[113]

From Autumn 2022, further booster doses were offered to:

• residents and staff in care homes for older adults,
• front line health and social care workers,
• people aged 50 years or older,
• people aged 5 years or older who are in a clinical risk group or who have immunosuppressed household contacts,
• people aged 16 years or older who are carers. ^[113]

Progress to date

By the end of the first full week of the programme, up to 15 December 2020, 137,897 people had been vaccinated with the first dose in the two-dose regimen: 108,000 in England, 7,897 in Wales, 4,000 in Northern Ireland and 18,000 in Scotland. ^{[114] [115]}

By 5 January 2021, 1.3 million people across the UK had received their first dose of either the Pfizer or Oxford–AstraZeneca COVID-19 vaccine, which included more than 650,000 people over 80, representing around 23% of that age band in England. ^[116]

As of 13 October 2021 ^[update] , a cumulative total of 49,252,939 people had received the first dose: 41,263,377 in England; 1,316,225 in Northern Ireland; 4,270,126 in Scotland and 2,403,211 in Wales. In addition, a cumulative total of 45,239,759 people had received the second dose: 37,918,254 in England; 1,221,045 in Northern Ireland; 3,868,656 in Scotland and 2,231,804 in Wales. ^[117]

As at 3 August 2022, a cumulative total of 53,710,109 people (80.07% of the entire UK population) had received the first dose, a cumulative total of 50,483,527 people (75.26%) had received the second dose, a cumulative total of 40,196,024 people (59.92%) had received the booster or third dose, and a cumulative total of 6,200,537 people (9.29%) had received a fourth dose; the total number of vaccinations given (first, second, third and fourth doses) were 150,590,197. ^[118]

Government vaccination updates increased from weekly to daily, from 11 January 2021. ^[116]

Weekly new and cumulative doses, by dose type, as at each week-ending date ^[117]

Previous WEEKLY figures		England		Northern Ireland		Scotland		Wales		UK TOTAL
Date	Dose	New	Cumulative	New	Cumulative	New	Cumulative	New	Cumulative	New	Cumulative
13 December 2020	1st	55,389 [lower-roman 1]	55,389	3,623	3,623	18,996	18,996	8,207	8,207	86,215	86,215
20 December 2020	1st	518,469	573,858	12,445	16,068	41,110	60,106	15,559	23,766	587,583	673,798
27 December 2020	1st	267,347	841,205	14,948	31,016	34,404	94,510	12,433	36,199	392,132	1,002,930
3 January 2021	1st	328,980	1,170,185	9,669	40,685	21,321	115,831	14,094	50,293	374,064	1,376,994
	2nd	20,565	20,565	1,271	1,271	43	43	26	26	21,905	21,905
	Total	349,545	1,190,750	10,940	41,956	21,364	115,874	14,120	50,319	395,969	1,398,899
10 January 2021	1st	951,951	2,122,136	38,395	79,080	51,109	166,940	41,212	91,505	1,082,667	2,459,661
	2nd	384,998	405,563	12,287	13,558	2,794	2,837	59	85	400,138	422,043
	Total	1,336,949	2,527,699	50,682	92,638	53,903	169,777	41,271	91,590	1,482,805	2,881,704
17 January 2021	1st	1,606,125	3,728,261	46,637	125,717	104,469	271,409	67,237	158,742	1,824,468	4,284,129
	2nd	40,372	445935	8,768	22,326	1,102	3,939	113	198	50,355	472,398
	Total	1,646,497	4,174,196	55,405	148,043	105,571	275,348	67,350	158,940	1,874,823	4,756,527
24 January 2021	1st	2,238,615	5,966,876	33,925	159,642	153,238	424,647	124,251	282,993	2,550,029	6,834,158
	2nd	6,480	452,415	387	22,713	2,049	5,988	370	568	9,286	481,684
	Total	2,245,095	6,419,291	34,312	182,355	155,287	430,635	124,621	283,561	2,559,315	7,315,842
31 January 2021	1st	2,189,803	8,156,679	62,167	221,809	164,922	589,569	160,504	443,497	2,577,396	9,411,554
	2nd	8,349	460,764	1,899	24,612	2,492	8,480	381	949	13,121	494,805
	Total	2,198,152	8,617,443	64,066	246,421	167,414	598,049	160,885	444,446	2,590,517	9,906,359
7 February 2021	1st	2,367,095	10,523,774	81,669	303,478	277,254	866,823	167,361	610,858	2,893,379	12,304,933
	2nd	8,395	469,159	2,851	27,463	3,038	11,518	1,872	2,821	16,156	510,961
	Total	2,375,490	10,992,933	84,520	330,941	280,292	878,431	169,233	613,679	2,909,535	12,815,894
14 February 2021	1st	2,343,180	12,862,909	93,765	397,243	388,367	1,255,190	180,833	784,809	3,006,145	15,300,151
	2nd	19,086	490,722	1,542	29,005	3,811	14,501	2,610	5,402	27,049	539,630
	Total	2,362,266	13,353,631	95,307	426,248	392,178	1,269,691	183,443	790,211	3,033,194	15,839,781
21 February 2021	1st	2,095,165	14,958,074	60,787	458,030	190,298	1,445,488	77,439	862,248	2,423,689	17,723,840
	2nd	22,713	513,435	1,791	30,796	22,841	37,342	37,350	42,752	84,695	624,325
	Total	2,117,878	15,471,509	62,578	488,826	213,139	1,482,830	114,789	905,000	2,508,384	18,348,165
28 February 2021	1st	2,254,730	17,212,804	67,370	525,400	166,090	1,611,578	63,421	925,669	2,551,611	20,275,451
	2nd	86,500	599,935	2,401	33,197	41,523	78,865	61,067	103,819	191,491	815,816
	Total	2,341,230	17,812,739	69,771	558,597	207,613	1,690,443	124,488	1,029,488	2,743,102	21,091,267
7 March 2021	1st	1,802,693	19,015,497	63,403	588,803	163,081	1,774,659	72,627	998,296	2,101,804	22,377,255
	2nd	197,386	797,321	9,654	42,851	39,867	118,732	79,920	183,739	326,827	1,142,643
	Total	2,000,079	19,812,818	73,057	631,654	202,948	1,893,391	152,547	1,182,035	2,428,631	23,519,898
14 March 2021	1st	1,776,341	20,791,838	40,658	629,461	134,332	1,908,991	124,635	1,122,931	2,075,966	24,453,221
	2nd	332,123	1,129,444	11,785	54,636	43,213	161,945	80,516	264,255	467,637	1,610,280
	Total	2,108,464	21,921,282	52,443	684,097	177,545	2,070,936	205,151	1,387,186	2,543,603	26,063,501
21 March 2021	1st	3,063,024	23,854,862	58,067	687,528	273,409	2,182,400	150,255	1,273,186	3,544,755	27,997,976
	2nd	492,103	1,621,547	34,047	88,683	63,151	225,096	81,803	346,058	671,104	2,281,384
	Total	3,555,127	25,476,409	92,114	776,211	336,560	2,407,496	232,058	1,619,244	4,215,859	30,279,360

Vaccination centres

Marshalling for COVID-19 vaccines at a medical centre in Wetherby, West Yorkshire.

A sign for a vaccination centre.

More than 70 sites across the UK were in operation at the end of the programme's first full week (15 December 2020). Whilst hospitals formed the centres initially, GP-led centres also started later in that week. ^[119]

Care home locations in England entered the programme on Wednesday 16 December. "Hundreds" of residents received the first dose in seven care homes in Slough, Aintree, Herne Bay, Thanet, Chalfont St Peter, Droitwich and Cheltenham. ^[120] Larger care homes (50 to 70 beds) were to be prioritised. ^[120]

The Chelsea Pensioners received their first dose at the Royal Hospital Chelsea on 23 December. ^[121]

Large venues such as sports stadia and exhibition centres started to be used as mass vaccination centres from 11 January 2021, ^[116] with seven such centres opening in England at Millennium Point, Birmingham; Ashton Gate Stadium, Bristol; ExCeL London; Manchester Tennis and Football Centre; Centre for Life, Newcastle; Robertson House, Stevenage; and Epsom Downs Racecourse, Surrey. ^[122] Seven mass vaccination centres were initially opened in Wales with that number increasing to 34 by February alongside 17 acute and community hospital sites. ^{[12] [123]}

Over 400 GP-led centres were rolling out the vaccination in Wales by the start of February. ^[123]

High street pharmacies in England started to administer the vaccine from 14 January 2021, with 6 chosen for the roll out initially. ^[124]

Places of worship also started to be used as large vaccination centres, with Salisbury Cathedral ^[125] and Lichfield Cathedral ^[126] among the first to make provisions from 15 January 2021; with the Al-Abbas Islamic Centre in Balsall Heath, Birmingham becoming the first mosque to offer the service on 21 January 2021. ^[127]

Popup events and mobile centres

Numerous pop-up vaccination events took place during the programme. Venues included mosques, churches, community centres, and food banks. ^[128] Tottenham Hotspur stadium hosted three vaccine events delivered by Morris House Group Practice during 2021 delivering over 10,000 vaccines and pushing Haringey to the top of the vaccine delivery at that time. ^[129] Many areas operated vaccine buses to increase convenience and enable patients not able to travel to be vaccinated. ^[130]

Locations

As of 28 May 2021 ^[update] , there were a total of 1,992 vaccination sites operating in England, ^{[lower-roman 2]} These were made up as follows: ^[131]

Number of vaccination sites in England, by region and type, as of 28 May 2021 ^[131]

Region	Hospital hubs	GP-Led vaccination services	Mass vaccination centres	Pharmacies	Totals
East of England	31	134	50	40	255
London	51	103	35	109	298
Midlands	40	189	20	96	345
North East and Yorkshire	46	173	17	96	332
North West	49	137	11	63	260
South East	39	180	18	66	303
South West	21	111	13	54	199
Grand Total	277	1,027	164	524	1992

• 
  Vaccination site locations in Wales, as at 15 January 2021
• 
  Vaccination site locations in England, as at 5 February 2021
• 
  Vaccination site locations in Scotland, as at 14 January 2021

Public opinion

Vaccine hesitancy

Further information: COVID-19 vaccine misinformation and hesitancy

A protest against COVID-19 vaccination in London during September 2021

Polling suggested that levels of vaccine hesitancy were fairly low in the UK compared to other parts of the world. YouGov's first survey on the subject in the middle of November 2020 suggested that 15% of British adults would refuse to get a COVID-19 vaccine which had fallen to just 6% (the lowest of any country polled) by April 2021. ^[7] Research by Ipsos MORI in May suggested that 99% of people who had received their first dose intended to take their second and 95% were certain they would. Whilst, indicating that 94% of the wider public had either had their first dose or intended to do when offered. ^[132] Research by the Office for National Statistics suggested that 96% of people over 16 had a positive attitude to the COVID-19 vaccine in early summer 2021. ^[133]

Though a large majority of people in all social groups were willing to take the vaccine, polling suggested that some demographics were more likely to display reluctance than others. Younger individuals were more likely to be uncertain than their elders. ^[7] Whilst, members of ethnic minority groups were more likely to be reluctant than white responders. ^[132] The November 2020 YouGov poll suggested that "leave" voters in the 2016 EU referendum were less likely to want the vaccine than "Remain" voters though this gap had closed by the spring. ^[7] Areas which showed higher levels of hesitancy towards the start of vaccine process included Inner East London, Outer West London, North East England, West Wales and the Valleys though reluctance fell significantly in these areas as the months went by. ^[133] Though the previously cited survey sampled public opinion in Great Britain (England, Scotland and Wales) one poll conducted in September 2021 suggested that the level of vaccine hesitancy in Northern Ireland was fairly high in comparison. ^[134]

Impact on political attitudes

It was suggested by commentators that the vaccine rollout strengthened support for the government with the Conservative Party enjoying an uptick in support in polls of voting intentions around spring 2021. ^[135] The so called "vaccine bounce" was widely cited by observers as one of the reasons for the party's gains at local elections in May 2021. ^[136] Polling at around this time suggested that 85% of British voters felt their government had handled the vaccine rollout well in comparison to less than a fifth of their French and German counterparts. ^[137] Analysts also suggested that this phenomenon may have contributed to a waning in support for Scottish independence in the run up to the 2021 Scottish parliament election. ^[138] The 'Mood of the Nation 2021' report by the consultancy firm BritainThinks based on research conducted in October and November 2021 found that whilst the optimistic mood around COVID-19 of the summer had rebaited the successful vaccine rollout remained one of few present day subjects which the general public in the UK cited as providing a sense of national pride. ^[139]

See also

• History of the COVID-19 pandemic in the United Kingdom
• Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
• Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
• Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
• British government response to the COVID-19 pandemic
• Deployment of COVID-19 vaccines
• European Commission–AstraZeneca COVID-19 vaccine dispute

Notes

1. England vaccination uptake data not published until 15 December 2020, so carried forward to next week ending
2. As of the stated date, location data for Scotland, Wales and Northern Ireland has not been published by the respective devolved authorities.

References

1. "England Summary | Coronavirus (COVID-19) in the UK". coronavirus.data.gov.uk. 20 July 2023. Archived from the original on 16 April 2020. Retrieved 27 December 2020.
2. Baraniuk, Chris (18 February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi: 10.1136/bmj.n421 . ISSN   1756-1833. PMID   33602672. S2CID   231946710. Archived from the original on 18 February 2021. Retrieved 13 January 2022.
3. Wise, Jacqui (14 September 2021). "Covid-19: Booster doses to be offered to 30 million people in UK". BMJ. 374: n2261. doi: 10.1136/bmj.n2261 . ISSN   1756-1833. PMID   34521637. S2CID   237508096. Archived from the original on 13 January 2022. Retrieved 13 January 2022.
4. Burki, Talha Khan (17 December 2021). "Omicron variant and booster COVID-19 vaccines". The Lancet Respiratory Medicine. 10 (2): e17. doi:10.1016/S2213-2600(21)00559-2. ISSN   2213-2600. PMC   8683118 . PMID   34929158.
5. "Explainer: why has the UK's vaccination rate slowed down?". The Guardian. 12 October 2021. Archived from the original on 19 October 2021. Retrieved 20 October 2021.
6. "The UK is about to hit its Covid vaccine ceiling". Wired UK. ISSN   1357-0978. Archived from the original on 20 October 2021. Retrieved 20 October 2021.
7. Smith, Matthew (28 April 2021). "Vaccine hesitancy has fallen across British society". yougov.co.uk. Archived from the original on 28 April 2021. Retrieved 2 October 2021.
8. Mahase, Elisabeth (4 June 2021). "Covid-19: UK has highest vaccine confidence and Japan and South Korea the lowest, survey finds". BMJ. 373: n1439. doi: 10.1136/bmj.n1439 . ISSN   1756-1833. PMID   34088703. S2CID   235337100. Archived from the original on 22 October 2021. Retrieved 20 October 2021.
9. "Coronavirus Vaccination sites". NHS England and NHS Improvement coronavirus. Archived from the original on 11 January 2021. Retrieved 1 June 2021.
10. "How you will get the vaccine". www.nhsinform.scot. Archived from the original on 20 August 2021. Retrieved 27 April 2021.
11. "COVID-19 vaccination programme weekly update: 25 May 2021". GOV.WALES. 25 May 2021. Archived from the original on 8 June 2021. Retrieved 31 May 2021.
12. Vaccination Strategy for Wales (PDF). Welsh Government. p. 10. Archived from the original (PDF) on 17 January 2021. Retrieved 12 January 2021.
13. Mills, Claire; Robinson, Timothy (19 January 2021). Coronavirus: UK support to the Overseas Territories (Report). Parliament of the United Kingdom. Archived from the original on 18 August 2021.
14. "Statement from the Chief Minister". Gov.je. 27 November 2020. Archived from the original on 10 March 2021. Retrieved 10 February 2020.
15. Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C (23 June 2022). "Global impact of the first year of COVID-19 vaccination: a mathematical modelling study". The Lancet Infectious Diseases . 22 (9): 1293–1302. doi:10.1016/s1473-3099(22)00320-6. ISSN   1473-3099. PMC   9225255 . PMID   35753318. Archived from the original on 29 June 2022. Retrieved 27 June 2022.
16. "COVID-19 vaccines saved nearly 20 million lives in a year, study says". CBS News . 24 June 2022. Archived from the original on 29 June 2022. Retrieved 27 June 2022.
17. "People who have received vaccinations, by nation". Coronavirus (COVID-19) in the UK. GOV.UK. Archived from the original on 4 August 2021. Retrieved 6 July 2021.
18. UK Census (2011). "Local Area Report – England (2092957699)". Nomis. Office for National Statistics . Retrieved 6 January 2021.
19. UK Census (2011). "Local Area Report – Scotland (2013265931)". Nomis. Office for National Statistics . Retrieved 6 January 2021.
20. UK Census (2011). "Local Area Report – Wales (2013265930)". Nomis. Office for National Statistics . Retrieved 6 January 2021.
21. UK Census (2011). "Local Area Report – Northern Ireland (2013265932)". Nomis. Office for National Statistics . Retrieved 23 September 2021.
22. "Ministerial role Parliamentary Under Secretary of State (Minister for COVID Vaccine Deployment)". Gov.uk. Department of Health and Social Care. 28 November 2020. Archived from the original on 15 August 2021. Retrieved 16 December 2020.
23. "An update on the coronavirus vaccine, 2 December 2020". Gov.uk. Department of Health and Social Care and The Rt Hon Matt Hancock MP. 2 December 2020. Retrieved 16 December 2020.
24. "Third Covid vaccine approved in the UK". BBC News. BBC. 8 January 2021. Archived from the original on 8 January 2021. Retrieved 8 January 2021.
25. "UK government secures additional 40 million doses of Valneva vaccine". Gov.uk. Department of Health and Social Care. 1 February 2021. Archived from the original on 27 June 2021. Retrieved 2 February 2021.
26. "New vaccines partnership to rapidly respond to new virus variants". Gov.uk. Archived from the original on 28 August 2021. Retrieved 7 February 2021.
27. "Covid: UK orders 35m extra Pfizer doses for booster jabs". BBC News. 23 August 2021. Archived from the original on 25 August 2021. Retrieved 23 August 2021.
28. "UK terminates vaccine contract with Valneva over supply issues". POLITICO. 13 September 2021. Archived from the original on 14 September 2021. Retrieved 14 September 2021.
29. "UK government secures additional 2 million doses of Moderna COVID-19 vaccine". Gov.uk. Department for Business, Energy & Industrial Strategy, Department of Health and Social Care, The Rt Hon Alok Sharma MP, and The Rt Hon Matt Hancock MP. 29 November 2020. Archived from the original on 15 December 2020. Retrieved 16 December 2020.
30. "What Covid vaccines does the UK have and which are in the works?". The Guardian. 25 April 2021. Archived from the original on 25 May 2021. Retrieved 27 April 2021.
31. "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator". Gov.uk. Department of Health and Social Care. 30 December 2020. Archived from the original on 16 March 2021. Retrieved 30 December 2020.
32. "Covid: Oxford vaccine rollout under way across the UK". BBC News. BBC. 4 January 2021. Archived from the original on 28 January 2021. Retrieved 4 January 2021.
33. "Patients in Wales to be first in UK to receive Moderna Covid vaccine". The Guardian. 7 April 2021. Archived from the original on 3 July 2021. Retrieved 7 April 2021.
34. "Janssen single-dose Covid vaccine approved by UK". BBC News. 28 May 2021. Archived from the original on 21 June 2021. Retrieved 28 May 2021.
35. "Novavax Covid jab approved by UK drugs regulator". BBC News. 2 February 2022. Archived from the original on 5 February 2022. Retrieved 5 February 2022.
36. "UK medicines regulator gives approval for first UK COVID-19 vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 2 December 2020. Archived from the original on 17 March 2021. Retrieved 16 December 2020.
37. "Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK". BBC. 2 December 2020. Archived from the original on 2 December 2020. Retrieved 2 December 2020.
38. "Comirnaty EPAR". European Medicines Agency (EMA). 21 December 2020. Archived from the original on 18 December 2021. Retrieved 17 January 2021.
39. "Decision: Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 16 December 2020. Archived from the original on 26 February 2021. Retrieved 16 December 2020.
40. "Covid: First batch of vaccines arrives in the UK". BBC. 3 December 2020. Archived from the original on 3 December 2020. Retrieved 3 December 2020.
41. "Novavax Vaccine Is 89% Effective Against Covid-19 in U.K. Study". 28 January 2021. Archived from the original on 29 August 2021. Retrieved 28 January 2021.
42. "Covid-19: Novavax vaccine shows 89% efficacy in UK trials". BBC News. 29 January 2021. Archived from the original on 30 January 2021. Retrieved 29 January 2021.
43. "Valneva Covid vaccine approved for use in UK". BBC News. 14 April 2022. Archived from the original on 14 April 2022. Retrieved 14 April 2022.
44. "First patient receives Pfizer Covid-19 vaccine". BBC. 8 December 2020. Archived from the original on 8 December 2020. Retrieved 16 December 2020.
45. "Hospitals to start biggest ever NHS Vaccination Programme this week". NHS. 6 December 2020. Archived from the original on 6 December 2020. Retrieved 20 June 2021.
46. Bodell, Matt (9 January 2021). "NHS organisations ordered to vaccinate staff 'as quickly as possible'". Nursing Notes. Archived from the original on 9 January 2021. Retrieved 20 June 2021.
47. "Vaccinating frontline social care workers". NHS. 14 January 2021. Archived from the original on 14 January 2021. Retrieved 20 June 2021.
48. "Covid-19: Vaccination rollout begins for over-70s in England". BBC News. BBC. 17 January 2021. Archived from the original on 27 June 2021. Retrieved 17 January 2021.
49. "COVID-19: Vaccine rollout begins for over-65s and clinically vulnerable people". Sky News. 14 February 2021. Archived from the original on 14 February 2021. Retrieved 20 June 2021.
50. "NHS invites people aged 60-plus to get life-saving COVID vaccination". NHS. 7 March 2021. Archived from the original on 28 February 2021. Retrieved 20 June 2021.
51. "NHS invites people aged 56 to 59 for their COVID jab". NHS. 7 March 2021. Archived from the original on 7 March 2021. Retrieved 20 June 2021.
52. "NHS England invites everyone aged 50 and over to be jabbed as NHS vaccination programme marks 100th day". NHS. 17 March 2021. Archived from the original on 17 March 2021. Retrieved 20 June 2021.
53. "Covid: People 45 or over in England invited to book vaccine". BBC News. 13 April 2021. Archived from the original on 13 April 2021. Retrieved 13 April 2021.
54. "Covid-19: Vaccine rollout in England extends to 44-year-olds". BBC News. 26 April 2021. Archived from the original on 25 April 2021. Retrieved 26 April 2021.
55. "Covid-19: Vaccine offered to 42-plus age group in England". BBC News. 27 April 2021. Archived from the original on 27 April 2021. Retrieved 27 April 2021.
56. "Covid-19 vaccine offered to people aged 40 and over in England". BBC News. 30 April 2021. Archived from the original on 30 April 2021. Retrieved 30 April 2021.
57. "Covid jabs offer to 38 and 39-year-olds in England". BBC News. 12 May 2021. Archived from the original on 12 May 2021. Retrieved 13 May 2021.
58. "NHS England » NHS invites people aged 36 and 37 for life-saving COVID-19 jab". www.england.nhs.uk. Archived from the original on 18 May 2021. Retrieved 18 May 2021.
59. "NHS England » NHS invites people aged 34 and 35 for life-saving COVID-19 jab". www.england.nhs.uk. Archived from the original on 29 June 2022. Retrieved 19 May 2021.
60. "NHS England » NHS England opens up life-saving COVID-19 jab offer to 32 and 33 year olds as England tops 50 million doses given". www.england.nhs.uk. Archived from the original on 22 May 2021. Retrieved 22 May 2021.
61. "Covid vaccine: 30 and 31-year-olds in England now invited". BBC News. 26 May 2021. Archived from the original on 26 May 2021. Retrieved 26 May 2021.
62. "Covid vaccine: 25 to 29-year-olds in England invited". BBC News. 7 June 2021. Archived from the original on 7 June 2021. Retrieved 7 June 2021.
63. "Covid: When will I get the vaccine?". BBC News. 14 June 2021. Archived from the original on 14 June 2021. Retrieved 15 June 2021.
64. Jackson, Marie (16 June 2021). "Covid vaccine to be compulsory for England care home staff". BBC News. Archived from the original on 15 June 2021. Retrieved 16 June 2021.
65. "Covid: All adults able to book coronavirus vaccination in England". BBC News. 18 June 2021. Archived from the original on 17 June 2021. Retrieved 18 June 2021.
66. "Covid-19 vaccine: Patient William Shakespeare second to get vaccination". BBC. 8 December 2020. Archived from the original on 21 May 2021. Retrieved 16 December 2020.
67. "'Pivotal moment' as Britain set to roll out AstraZeneca vaccine". Reuters. 4 January 2021. Archived from the original on 16 April 2022. Retrieved 4 January 2021.
68. "Covid-19: Queen and Prince Philip receive vaccinations". BBC News. BBC. 9 January 2021. Archived from the original on 28 August 2021. Retrieved 17 January 2021.
69. Cope, Emily. "Prince William urges the public to follow the queen's example and get COVID jab". The Independent. No. 16 January 2021. Independent Digital News & Media Ltd. Archived from the original on 12 February 2021. Retrieved 17 January 2021.
70. "Prime Minister's address to the nation: 4 January 2021". Gov.uk. Prime Minister's Office, 10 Downing Street and The Rt Hon Boris Johnson MP. 4 January 2021. Archived from the original on 27 August 2021. Retrieved 4 January 2021.
71. "COVID-19 vaccine: 20 million people have received first coronavirus jab in UK". Sky News. Archived from the original on 13 June 2021. Retrieved 28 February 2021.
72. "COVID-19: Boris Johnson receives first dose of Oxford-AstraZeneca vaccine". Sky News. Archived from the original on 8 August 2021. Retrieved 7 May 2021.
73. "Covid: Moderna vaccine UK rollout begins in Wales". BBC News. 7 April 2021. Archived from the original on 14 July 2021. Retrieved 7 April 2021.
74. "Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 9 December 2020. Retrieved 18 December 2020.
75. "Coronavirus (COVID-19): antibody testing". Gov.uk. Department of Health & Social Care. 17 December 2020. Archived from the original on 18 December 2020. Retrieved 18 December 2020.
76. "COVID-19 (SARS-CoV-2): information about the new virus variant". Gov.uk. Public Health England. 20 December 2020. Archived from the original on 20 December 2021. Retrieved 21 December 2020.
77. Engl, Public Health. "New JCVI advice on use of the AstraZeneca COVID-19 vaccine". GOV.UK. Archived from the original on 8 April 2021. Retrieved 8 April 2021.
78. Engl, Public Health. "JCVI advises on COVID-19 vaccine for people aged under 40". GOV.UK. Archived from the original on 7 May 2021. Retrieved 8 May 2021.
79. "Covid-19: Most vulnerable 'could get vaccine by Christmas'". BBC News. 17 October 2020. Archived from the original on 16 June 2023. Retrieved 21 December 2020.
80. "Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI". GOV.UK. Department of Health and Social Care. 2 December 2020. Archived from the original on 2 December 2020. Retrieved 21 December 2020.
81. Bingham, Kate (27 October 2020). "The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world". The Lancet. 397 (10268): 68–70. doi: 10.1016/S0140-6736(20)32175-9 . PMC   7833709 . PMID   33125932.
82. "Covid-19: Vaccination targets could be exceeded, says Kate Bingham". BBC News. 8 January 2021. Archived from the original on 12 January 2021. Retrieved 16 January 2021.
83. "Independent batch release testing of COVID-19 (coronavirus) vaccines by the NIBSC". GOV.UK. Medicines and Healthcare products Regulatory Agency. 22 December 2020. Archived from the original on 23 December 2020. Retrieved 23 December 2020.
84. "Coronavirus Yellow Card reporting site". MHRA. Archived from the original on 7 May 2020. Retrieved 11 February 2021.
85. "2020 Review". VMIC. 21 December 2020. Archived from the original on 21 January 2021. Retrieved 22 March 2021.
86. Clark, Lindsay (28 June 2021). "Serco bags £322m contract extension for Test and Trace, is still struggling to share data with local authorities". www.theregister.com. Archived from the original on 28 June 2021. Retrieved 10 January 2022.
87. "COVID: How The Military's Been Involved In Fighting Coronavirus". BFBS . 18 February 2021. Archived from the original on 20 September 2021. Retrieved 12 August 2021.
88. "Covid-19: First vaccine patient has her second jab". BBC. 29 December 2020. Archived from the original on 29 December 2020. Retrieved 29 December 2020.
89. Mahase, Elisabeth (31 December 2020). "Covid-19: Order to reschedule and delay second vaccine dose is "totally unfair," says BMA". British Medical Journal. 371: m4978. doi: 10.1136/bmj.m4978 . PMID   33384299.
90. "Letter to the profession from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes". Gov.uk. Department of Health and Social Care. 31 December 2020. Archived from the original on 31 December 2020. Retrieved 3 January 2020.
91. Hayward, Will (11 January 2021). "Wales sets three targets for coronavirus vaccine rollout". WalesOnline. Archived from the original on 12 January 2021. Retrieved 12 January 2021.
92. "Coronavirus (COVID-19): vaccine deployment plan 2021 – gov.scot". gov.scot. Retrieved 16 January 2021.
93. Manthorpe, Rowland (16 January 2021). "COVID-19: Every UK adult could be vaccinated by mid-July – if these figures are anything to go by". Sky News. Archived from the original on 16 January 2021. Retrieved 16 January 2021.
94. "Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination". GOV.UK. Department of Health & Social Care. 30 December 2020. Archived from the original on 17 February 2021. Retrieved 7 January 2021.
95. "UK COVID-19 vaccines delivery plan" (PDF). GOV.UK. Department of Health & Social Care. 11 January 2021. Archived (PDF) from the original on 13 October 2022. Retrieved 12 February 2021.
96. "Covid: When will I get the vaccine?". BBC News.uk. 19 February 2021. Archived from the original on 19 February 2021. Retrieved 20 February 2021.
97. "Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19". Gov.uk. Department of Health & Social Care and Public Health England. 14 December 2020. Archived from the original on 28 November 2022. Retrieved 16 December 2020.
98. Sommerlad, Joe (4 January 2021). "When will I get the Covid vaccine? Online calculator estimates your place in the queue". The Independent. Archived from the original on 3 January 2021. Retrieved 4 January 2021.
99. O'Reilly, April Roach, Luke (16 February 2021). "When will you get the Covid vaccine? Online calculator estimates date". www.standard.co.uk. Archived from the original on 16 May 2024. Retrieved 10 June 2021.
100. "People at high risk from coronavirus (clinically extremely vulnerable)". Gov.uk. Department of Health & Social Care and Public Health England. 5 March 2021. Archived from the original on 19 February 2022. Retrieved 13 March 2021.
101. "JCVI interim statement on phase 2 of the COVID-19 vaccination programme". GOV.UK. Archived from the original on 4 March 2021. Retrieved 8 March 2021.
102. "Age not job prioritised in second phase of Covid jab rollout". BBC News. 26 February 2021. Archived from the original on 27 October 2022. Retrieved 8 March 2021.
103. Gallagher, James (19 July 2021). "Covid: Hundreds of thousands of under-18s to get vaccine". BBC News. Archived from the original on 8 October 2021. Retrieved 8 October 2021.
104. "UK to roll out COVID-19 vaccines to 16 and 17-year-olds". news.yahoo.com (from associated press). 4 August 2021. Archived from the original on 4 August 2021. Retrieved 8 October 2021.
105. Roxby, Philippa; Triggle, Nick (3 September 2021). "Scientists not backing Covid jabs for 12 to 15-year-olds". BBC News. Archived from the original on 8 October 2021. Retrieved 8 October 2021.
106. Triggle, Nick; Roxby, Philippa (13 September 2021). "Covid: Single jab recommended for 12 to 15-year-olds by UK's top doctors". BBC News. Archived from the original on 8 October 2021. Retrieved 8 October 2021.
107. "COVID-19: Booster jabs for all adults as vaccine advisers announce rollout expansion to combat Omicron variant". Sky News. Archived from the original on 29 November 2021. Retrieved 29 November 2021.
108. Morris, Sophie (16 February 2022). "COVID-19: All children aged 5–11 in UK will be offered coronavirus vaccine as England and Northern Ireland become latest nations to confirm plan". Sky News. Archived from the original on 16 February 2022. Retrieved 16 February 2022.
109. "JCVI statement on vaccination of children aged 5 to 11 years old". GOV.UK. 16 February 2022. Archived from the original on 16 February 2022. Retrieved 16 February 2022.
110. "Coronavirus (COVID-19) vaccine for children aged 5 to 15". nhs.uk. 2 April 2022. Archived from the original on 18 September 2022. Retrieved 16 September 2022.
111. Knapton, Sarah (14 September 2021). "Booster vaccine offered to over-50s within days" . The Telegraph. ISSN   0307-1235. Archived from the original on 12 January 2022. Retrieved 8 October 2021.
112. "Covid booster doses will be offered to over-40s". BBC News. 15 November 2021. Archived from the original on 16 November 2021. Retrieved 16 November 2021.
113. "COVID-19 – SARS-CoV-2". Immunisation against infectious disease (PDF). UK Health Security Agency. 5 September 2022. Archived (PDF) from the original on 16 May 2024. Retrieved 27 September 2022.
114. Lay, Kat; Blakely, Rhys (17 December 2020). "138,000 vaccinated in a week". The Times. No. 73, 345. p. 5. ISSN   0140-0460.
115. Parsons, Rob (17 December 2020). "Minister hails 'good start to vaccine roll-out'". The Yorkshire Post. p. 5. ISSN   0963-1496.
116. "Prime Minister's statement on coronavirus (COVID-19): 5 January 2021". Gov.uk. Prime Minister's Office, 10 Downing Street and The Rt Hon Boris Johnson MP. 5 January 2021. Archived from the original on 5 January 2021. Retrieved 6 January 2021.
117. "People who have received vaccinations, by nation". Coronavirus (COVID-19) in the UK. GOV.UK. Archived from the original on 13 April 2022. Retrieved 24 March 2021.
118. Gov.uk Coronavirus website as at 3 August 2022 @ 4.45 pm.
119. "More than 137,000 people in UK receive first dose of COVID vaccine in one week". Gov.uk. Department of Health & Social Care. 16 December 2020. Archived from the original on 17 December 2020. Retrieved 17 December 2020.
120. "Over 600,000 people get first dose of Pfizer/BioNTech vaccine". Gov.uk. Department of Health and Social Care. 24 December 2020. Archived from the original on 26 December 2020. Retrieved 26 December 2020.
121. "Covid vaccine: Chelsea Pensioners receive jab 'gift'". BBC News. BBC. 23 December 2020. Archived from the original on 23 December 2020. Retrieved 26 December 2020.
122. "Covid: Mass vaccination centres to open in England". BBC News. BBC. 11 January 2021. Archived from the original on 11 January 2021. Retrieved 11 January 2021.
123. "COVID-19 vaccination programme weekly update: 2 February 2021". GOV.WALES. 2 February 2021. Archived from the original on 2 February 2021. Retrieved 6 February 2021.
124. "Covid-19: High Street chemists start vaccinations in England". BBC News. BBC. 14 January 2021. Archived from the original on 14 January 2021. Retrieved 14 January 2021.
125. "RAF veteran receives Covid jab at Salisbury Cathedral". BBC News. BBC. 16 January 2021. Archived from the original on 16 January 2021. Retrieved 17 January 2021.
126. "Covid-19: Lichfield Cathedral turned into vaccination centre". BBC News. 15 January 2021. Archived from the original on 14 April 2021. Retrieved 16 January 2021.
127. "Birmingham mosque becomes UK's first to offer Covid vaccine". BBC News. BBC. 21 January 2021. Archived from the original on 23 January 2021. Retrieved 24 January 2021.
128. "Pop-up vaccination clinics coming to Haringey | Haringey Council". www.haringey.gov.uk. Archived from the original on 28 October 2022. Retrieved 28 October 2022.
129. Lydall, Ross (23 June 2021). "London vaccinations by borough: Mass jabs sends new borough to top". Evening Standard. Retrieved 28 October 2022.
130. "The vaccine bus is coming". University College London Hospitals NHS Foundation Trust. Archived from the original on 28 October 2022. Retrieved 28 October 2022.
131. "Vaccination sites". NHS.uk. NHS England. Archived from the original on 23 December 2020. Retrieved 8 April 2021.
132. "An Ipsos MORI study shows confidence in the vaccine remains high". Ipsos Mori. 20 May 2021. Archived from the original on 2 October 2021. Retrieved 2 October 2021.
133. "Coronavirus and vaccine hesitancy, Great Britain – Office for National Statistics". www.ons.gov.uk. 9 August 2021. Archived from the original on 9 August 2021. Retrieved 2 October 2021.
134. "Research finds vaccine hesitancy higher among young people". BreakingNews.ie. 27 September 2021. Archived from the original on 16 May 2024. Retrieved 2 October 2021.
135. Ridge, Sophy (1 May 2021). "Is 'vaccine bounce' proving a shot in the arm for Boris Johnson amid growing sleaze row?". Sky News. Archived from the original on 1 May 2021. Retrieved 4 October 2021.
136. Parker, George; Cameron-Chileshe, Jasmine (7 May 2021). "Johnson's popularity and 'vaccine bounce' propel Tories to election success in Labour heartlands". Financial Times. Archived from the original on 4 October 2021. Retrieved 4 October 2021.
137. "A Conservative triumph in Hartlepool is a bleak day for Labour". The Economist. 7 May 2021. ISSN   0013-0613. Archived from the original on 4 October 2021. Retrieved 4 October 2021.
138. Devlin, Kate (20 March 2021). "Fall in support for Scottish independence could be result of a 'vaccine bounce', analysis suggests". The Independent. Archived from the original on 20 March 2021. Retrieved 4 October 2021.
139. "Mood of the Nation 2021" (PDF). BritainThinks. December 2021. Archived (PDF) from the original on 21 December 2021. Retrieved 27 December 2021.

External links

• COVID-19 vaccination programme (Gov.uk)
• COVID-19 vaccination programme (NHS England)
• Coronavirus (COVID-19) vaccine (NHS Scotland)
• Coronavirus (COVID-19) vaccination programme (Welsh Government)
• COVID-19 vaccination programme in Northern Ireland (NI direct)
• COVID-19 United Kingdom government statistics
• Adverse reactions reports – Medicines and Healthcare products Regulatory Agency
• Covid-19 vaccination tracker in the United Kingdom – with historical data grouped by day Archived 19 November 2021 at the Wayback Machine